Key result
Expression of the CASQ2(D307H) mutation in rat myocytes impaired SR Ca2+ storing and release functions, destabilizing the Ca2+-induced Ca2+ release mechanism.
Population
Adult rat myocytes
Comparison
Adenoviral-directed expression of a canine CASQ2… vs Adenoviruses expressing wild-type CASQ2 (CASQ2)
Design
Preclinical
Authors
Loading...
Hypothesis-generating for CPVT mechanisms; leaves open translation to human therapies pending validation studies.
The CASQ2(D307H) mutation impairs SR calcium handling and destabilizes calcium-induced calcium release, providing a cellular mechanism for adrenergically mediated arrhythmias in CPVT.
Viatchenko‐Karpinski et al. (2004) studied Catecholaminergic polymorphic ventricular tachycardia. Adenoviral-directed expression of CASQ2(D307H) vs. Adenoviruses expressing wild-type CASQ2 (CASQ2(WT)) was evaluated on SR Ca2+ storing capacity and Ca2+ release functions. Expression of the CASQ2(D307H) mutation in rat myocytes impaired SR Ca2+ storing and release functions, destabilizing the Ca2+-induced Ca2+ release mechanism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: